Thursday, February 01, 2024 7:32:09 PM
The purpose of the RS was to essentially wipe away the legacy stock from the previous business of LEAS and award the owners of ANEW (who hold those preferred shares that were to convert after the RS was complete) with the lion's share of the equity in this company. Because the CEO has voting control, he can simply take the RWOD stock and divide it amongst his classes of stock as he sees fit. He owned 30% of ANEW prior to merging it into LEAS, and I expect he'll want to own a similar stake of the RWOD shares awarded in the business combination.
I know that doesn't directly answer your question, but do you really think that you're going to get a windfall from buying stock that barely trades on the OTC from a NASDAQ SPAC wanting to buy a $1.3M company for $60M?
I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM